227 related articles for article (PubMed ID: 19892833)
1. BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses.
Shih SR; Horng JT; Poon LL; Chen TC; Yeh JY; Hsieh HP; Tseng SN; Chiang C; Li WL; Chao YS; Hsu JT
J Antimicrob Chemother; 2010 Jan; 65(1):63-71. PubMed ID: 19892833
[TBL] [Abstract][Full Text] [Related]
2. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
[TBL] [Abstract][Full Text] [Related]
3. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.
Hu Y; Zhang J; Musharrafieh R; Hau R; Ma C; Wang J
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885544
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
Puzelli S; Facchini M; Di Martino A; Fabiani C; Lackenby A; Zambon M; Donatelli I
Antiviral Res; 2011 Jun; 90(3):205-12. PubMed ID: 21514326
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
[TBL] [Abstract][Full Text] [Related]
6. An Influenza Virus Entry Inhibitor Targets Class II PI3 Kinase and Synergizes with Oseltamivir.
O'Hanlon R; Leyva-Grado VH; Sourisseau M; Evans MJ; Shaw ML
ACS Infect Dis; 2019 Oct; 5(10):1779-1793. PubMed ID: 31448902
[TBL] [Abstract][Full Text] [Related]
7. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
[TBL] [Abstract][Full Text] [Related]
8. Ching-fang-pai-tu-san inhibits the release of influenza virus.
Hsieh CF; Yen HR; Liu CH; Lin S; Horng JT
J Ethnopharmacol; 2012 Dec; 144(3):533-44. PubMed ID: 23041224
[TBL] [Abstract][Full Text] [Related]
9. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
[TBL] [Abstract][Full Text] [Related]
10. Allele-specific conventional reverse-transcription polymerase chain reaction as a screening assay for discriminating influenza a H1N1 (H275Y) oseltamivir-resistant and wild-type viruses.
Ngai KL; Lam WY; Lee N; Leung TF; Hui DS; Chan PK
J Med Virol; 2010 Aug; 82(8):1295-8. PubMed ID: 20572070
[TBL] [Abstract][Full Text] [Related]
11. [Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].
Reina J
Rev Esp Quimioter; 2006 Dec; 19(4):317-22. PubMed ID: 17235399
[No Abstract] [Full Text] [Related]
12. Dextran sulfate-resistant A/Puerto Rico/8/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein.
Yamada H; Nagao C; Haredy AM; Mori Y; Mizuguchi K; Yamanishi K; Okamoto S
Antiviral Res; 2014 Nov; 111():69-77. PubMed ID: 25234090
[TBL] [Abstract][Full Text] [Related]
13. The effects of neuraminidase inhibitors on the release of oseltamivir-sensitive and oseltamivir-resistant influenza viruses from primary cultures of human tracheal epithelium.
Yamaya M; Nadine L; Kubo H; Saito K; Saito R; Nishimura H
J Med Virol; 2015 Jan; 87(1):25-34. PubMed ID: 24838828
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
Gubareva LV; Webster RG; Hayden FG
Antimicrob Agents Chemother; 2001 Dec; 45(12):3403-8. PubMed ID: 11709315
[TBL] [Abstract][Full Text] [Related]
15. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
Huang L; Zhou JF; Wei H; Shu YL
Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
[TBL] [Abstract][Full Text] [Related]
16. Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.
Correia V; Santos LA; Gíria M; Almeida-Santos MM; Rebelo-de-Andrade H
J Med Virol; 2015 Jan; 87(1):45-56. PubMed ID: 25042157
[TBL] [Abstract][Full Text] [Related]
17. Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
Nguyen HT; Trujillo AA; Sheu TG; Levine M; Mishin VP; Shaw M; Ades EW; Klimov AI; Fry AM; Gubareva LV
Antiviral Res; 2012 Mar; 93(3):381-6. PubMed ID: 22330888
[TBL] [Abstract][Full Text] [Related]
18. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
[TBL] [Abstract][Full Text] [Related]
19. Neuraminidase inhibitor resistance in influenza viruses.
Reece PA
J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169
[TBL] [Abstract][Full Text] [Related]
20. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
Duwe SC; Wedde M; Birkner P; Schweiger B
Antiviral Res; 2011 Jan; 89(1):115-8. PubMed ID: 21070812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]